Latest Health News

Bubalus Resources has streamlined its project portfolio and cut corporate costs, sharpening its focus on priority gold and critical minerals assets in Victoria and the Northern Territory.

BlinkLab’s smartphone-based Dx1 autism screening technology has been selected for Morocco’s government-funded national early screening program, marking a major milestone in digital health adoption and autism care.

Cyclopharm has secured a significant multi-site agreement with the University of Pennsylvania Health System, marking a major step in its US expansion with installations across 11 clinical locations.

Nexsen Limited has successfully completed a pivotal FDA Pre-Submission meeting for its StrepSure® diagnostic, significantly reducing regulatory risks and advancing its entry into the large US maternal health market.

Enlitic has secured a $1.5 million contract to migrate over 71 million clinical files for Penn Medicine Doylestown Health, reinforcing its foothold in the US healthcare IT sector.

EVE Health Group has announced a $1.3 million capital raising through a placement of shares and free attaching options, aimed at advancing its pharmaceutical product rollout and development pipeline. Several components of the offer await shareholder approval at an upcoming general meeting.

Premier Investments reported a modest 0.38% rise in net profit from continuing operations for the half-year ending January 2026, alongside a 3% increase in revenue and a fully franked interim dividend of 45 cents per share.

CLINUVEL Pharmaceuticals reports record first-half profits and confirms CEO Philippe Wolgen’s leadership through a pivotal growth phase, prioritising its vitiligo program and Nasdaq ambitions.

Nexalis Therapeutics has initiated dosing in its Phase 1 trial of IRX-616a, a novel cannabidiol inhalation treatment targeting panic disorder. The trial aims to evaluate safety and pharmacokinetics, with dose escalation decisions expected soon.

OMG Group has appointed Food & Dairy Co as the first official distributor of its new matcha brands, opening access to over 2,000 cafes and restaurants in NSW and Queensland. This move marks a key step in OMG’s strategy to expand its health-focused beverage portfolio.

EVE Health Group has increased its placement funding to $1.3 million, backed by a cornerstone investor with pharmaceutical expertise, advancing its reformulated drug programs targeting billion-dollar global markets.

Meteoric Resources hosted Minas Gerais Governor Romeu Zema at its Caldeira Rare Earth Project pilot plant, highlighting continuous production success and strong government backing for the project’s expansion.